Stopping Premedication for Weekly Paclitaxel in Breast Cancer
Part of Cancer, Immune system & allergy, Skin clinical trials.
This trial is testing whether it's safe to stop the routine allergy-prevention medications (premedication) given before weekly paclitaxel chemotherapy in patients with non-metastatic breast cancer. The goal is to see if stopping these medications improves your quality of life during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have breast cancer that has not spread to other parts of your body (non-metastatic)
- You are getting weekly paclitaxel chemotherapy alone for 12 weeks at a participating hospital
- You did not have an allergic reaction to your first or second dose of paclitaxel
- You are not taking oral steroids for more than 2 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a daily tablet (Onlife) can help prevent nerve side effects (“neurotoxicity”) caused by weekly paclitaxel given for breast cancer. You’d be randomly assigned to the tablet or a placebo, and you would be closely followed with questionnaires and clinic visits.
This early-phase study tests how epidiferphane works in the body and whether it is safe when combined with standard chemotherapy “taxanes” (paclitaxel or docetaxel) for breast cancer. If you qualify, you may be starting a new taxane treatment plan at the study site, and you would be followed closely for side effects and drug levels.
This study looks at how physical activity and body composition affect the side effects of paclitaxel, a chemotherapy drug, in women with stage II or III breast cancer. It aims to help doctors understand who might have more or fewer side effects during treatment.
This trial tests paclitaxel given as tiny micelle particles for people whose cancer (pancreatic, bile duct, lung, stomach, esophagus, or breast) stopped responding to taxane chemotherapy or did not shrink. The goal is to see if this treatment can help when standard taxanes no longer work.
This trial tests whether cryotherapy (cooling the hands/feet during chemo) can prevent or lessen nerve pain caused by paclitaxel in people with early breast cancer. It may help you stay more comfortable and function better during treatment.
This trial studies how paclitaxel (a chemotherapy medicine) behaves in the body when given by a specific 1-hour infusion approach. It may help refine dosing for people with cancer using measurements from scans, and it includes a medicine schedule you must match.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.